The BCR-ABL 35 INS insertion / truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia *
暂无分享,去创建一个
B. Druker | A. Corbin | M. Deininger | A. Agarwal | V. Rivera | H. You | T. O'hare | R. Press | C. Eide | M. Zabriskie | Fei Yang | Lauren T. Adrian | J. Toplin | S. Wong